Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The intestinal mucosal epithelium and gut barrier represent a complex multi-layered system that separates the internal environment of the body from the external luminal contents of the gastrointestinal tract (Vancamelbeke & Vermeire, 2017, Expert Rev Gastroenterol Hepatol). It consists of a physical barrier composed of a mucus layer and a single layer of specialized epithelial cells (enterocytes, goblet cells, Paneth cells), a chemical barrier of antimicrobial peptides, and an immunological barrier comprising the gut-associated lymphoid tissue (Bischoff et al., 2014, BMC Gastroenterol). The primary biological function is to facilitate the selective absorption of nutrients, water, and electrolytes while preventing the translocation of pathogens, toxins, and pro-inflammatory antigens into the systemic circulation (NIH, StatPearls, 2023). Dysfunction of this barrier, often characterized by increased permeability or leaky gut, is a central feature in the pathogenesis of various inflammatory and autoimmune diseases, including Crohn's disease and ulcerative colitis (Chelakkot et al., 2018, Exp Mol Med). While not a single molecular target, therapeutic strategies focus on reinforcing its components, such as regulating tight junction proteins like claudins and occludin or using growth factors like Teduglutide to promote mucosal repair (Groschwitz & Hogan, 2009, J Allergy Clin Immunol). Current drug development aims to restore barrier integrity to prevent the systemic inflammation driven by intestinal dysbiosis and permeability.
Modulation of tight junction proteins (e.g., zonulin antagonism), stimulation of epithelial cell proliferation via GLP-2 analogs, reduction of mucosal inflammation through cytokine inhibition, and enhancement of the protective mucus layer.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal mucosal epithelium and gut barrier.